×
Select Your Country
What if a silent disease was threatening the health of millions of men, and most didn’t even know it?
Prostate cancer is one of the most common cancers affecting men worldwide. In India alone, over 40,500 new cases are diagnosed each year, yet awareness remains alarmingly low. By understanding what prostate cancer is, recognising its early warning signs, knowing its causes, and exploring the latest treatment options, men can take control of their health and make informed decisions that could save lives.
The prostate gland, which is a small, walnut-shaped organ in males that makes seminal fluid, is where prostate cancer starts. Seminal fluid is important for feeding and moving sperm. Most of the time, this kind of cancer grows slowly, but sometimes it can be aggressive and spread quickly.
Most of the time, males over 50 are the ones who are diagnosed. It's also crucial to remember that the survival rate for prostate cancer is fairly high when it's found early, especially before it extends beyond the prostate gland.
Early-stage prostate cancer symptoms often go unnoticed, which is why regular screenings after age 50 are vital. However, as the cancer progresses, men may start to experience symptoms. Recognising the signs of prostate cancer early can be life-saving.
Common Symptoms Include:
Difficulty in starting or stopping urination
Weak or interrupted urine stream
Frequent urination, especially at night
Pain or burning during urination
Blood in urine or semen
Pain in the lower back, hips, or thighs
Erectile dysfunction
If you or someone you know is experiencing these symptoms, a prostate cancer diagnosis through a PSA test or biopsy may be necessary.
Prostate cancer develops when cells in the prostate gland begin to grow uncontrollably. While the exact cause of prostate cancer is not fully understood, researchers believe it results from a combination of genetic, hormonal, lifestyle, and environmental factors. The disease typically begins when mutations occur in the DNA of prostate cells, leading to abnormal growth and division. Over time, these abnormal cells may form a tumour that can spread to nearby tissues or other parts of the body.
Understanding the root causes is only part of the picture—certain individuals are more likely to develop prostate cancer due to specific risk factors that further influence its onset and severity.
Age
The risk rises significantly after the age of 50, and most cases are diagnosed in men over 65.
As men age, hormonal changes, DNA damage accumulation, and a decline in immune surveillance may contribute to cancer development.
Family History
Men with a first-degree relative (father, brother, or son) who has had prostate cancer are twice as likely to develop it themselves.
The risk increases further if multiple family members are affected or if the cancer was diagnosed at a younger age.
Inherited gene mutations such as BRCA1 and BRCA2 have also been associated with aggressive prostate cancer.
Race and Ethnicity
African-American men are at higher risk and tend to develop more aggressive forms of the disease.
They also face a higher mortality rate, possibly due to genetics, socioeconomic factors, healthcare access, and environmental influences.
Men of Asian and Hispanic descent generally have lower incidence rates.
Diet and Lifestyle
Diets high in saturated fats (especially from red and processed meats) and low in fruits and vegetables are linked to a higher risk.
Excessive calcium intake, particularly from supplements, may increase risk.
Nutrient-rich foods like tomatoes (lycopene), green tea, soy, and cruciferous vegetables may help reduce risk.
Obesity and Physical Inactivity
Obese men are more likely to develop aggressive or advanced prostate cancer.
Fat tissue can alter hormone levels, including testosterone and oestrogen, influencing tumour growth.
Obesity is also associated with higher insulin and inflammation levels, which can worsen prognosis.
Staying active improves outcomes and may lower risk.
Type of Prostate Cancer | Aggressiveness | PSA Production | Common Sites of Origin/Spread |
Adenocarcinoma | Varies (most are slow-growing, but some can be aggressive) | Yes – usually produces PSA | Starts in the prostate gland |
Small Cell Carcinoma | High – often diagnosed at an advanced stage | No – typically does not produce PSA | May spread quickly to bones, liver, or lungs |
Squamous Cell Carcinoma | High – faster growing than adenocarcinoma | No – does not produce PSA | It can spread rapidly to nearby tissues and distant organs |
Transitional Cell Carcinoma | Moderate to High | May produce low or no PSA | Originates in the urinary bladder; spreads to the urethra, prostate, or nearby organs |
Early detection of prostate cancer plays a vital role in improving treatment outcomes and survival rates. Diagnosis typically involves a step-by-step approach combining blood tests, physical exams, imaging, and tissue analysis.
PSA Test (Prostate-Specific Antigen)
A blood test that measures PSA levels, which tend to be elevated in men with prostate cancer.
While not cancer-specific, persistently high or rising PSA levels can prompt further testing.
Digital Rectal Exam (DRE)
A physical exam where a doctor feels the prostate through the rectum to check for lumps or hard areas.
DRE may detect abnormalities not reflected in PSA levels.
Imaging (MRI or Transrectal Ultrasound)
Multiparametric MRI is often used to assess suspicious areas in detail.
Ultrasound may be used during biopsy or when an MRI is unavailable.
Imaging helps determine the extent and location of abnormal tissue.
Prostate Biopsy
A sample of prostate tissue is collected (usually via a needle guided by ultrasound or MRI).
The tissue is examined under a microscope to confirm the presence of cancer cells.
Once cancer is confirmed, it’s important to determine how aggressive it is and how far it has spread. This guides treatment planning.
Gleason Score (Grading System)
Assess how abnormal the cancer cells look under a microscope.
Scores range from 6 to 10 (with 6 being low-grade and 8–10 being high-grade).
Higher Gleason scores indicate more aggressive cancer.
TNM Staging System (Tumour–Node–Metastasis)
T (Tumour): Size and extent of the tumour in the prostate.
N (Nodes): Whether cancer has spread to nearby lymph nodes.
M (Metastasis): Whether cancer has spread to other organs, such as bones or lungs.
Treatment Option |
Best Suited For |
Common Risks/Side Effects |
Recovery Time |
Active Surveillance |
Men with low-risk, slow-growing prostate cancer |
Anxiety from regular monitoring; possible missed window if cancer becomes aggressive |
N/A – ongoing monitoring |
Surgery (Radical Prostatectomy) |
Localised prostate cancer in healthy patients |
Urinary incontinence, erectile dysfunction, infection, bleeding |
4–6 weeks for initial recovery; full recovery may take several months |
Radiation Therapy |
Local or locally advanced cancer; also used post-surgery |
Fatigue, bowel issues, urinary problems, and erectile dysfunction |
A few weeks to a few months, depending on the type |
Hormone Therapy (Androgen Deprivation Therapy) |
Advanced or recurrent prostate cancer |
Hot flashes, bone thinning, decreased libido, weight gain, mood swings |
Ongoing – managed with medications or injections |
Advanced, metastatic, or hormone-resistant prostate cancer |
Hair loss, nausea, low immunity, fatigue, neuropathy |
Several months (cycle-based) |
|
Immunotherapy |
Select cases of advanced or genetically driven prostate cancer |
Autoimmune reactions, fatigue, skin rashes, diarrhoea |
Varies by drug (weeks to months)
|
Although not all prostate cancers can be prevented, certain lifestyle changes can reduce your risk. Here’s how you can focus on prostate cancer prevention:
Eat a diet rich in fruits and vegetables
Maintain a healthy weight
Exercise regularly
Limit intake of red meat and high-fat dairy
Avoid smoking
Get regular screenings after age 50 or earlier if you’re at high risk
By incorporating these habits, men can potentially lower their risk and detect any problems early.
The prostate cancer survival rate varies based on the stage at which it’s diagnosed:
Localised Cancer: 5-year survival rate is nearly 100%
Regional Spread: 5-year survival is about 99%
Distant Spread (Metastatic): Drops to about 32%
These statistics emphasise the importance of early detection and prompt treatment.
Understanding what prostate cancer is, recognising its early symptoms, knowing your risk factors, and exploring available treatment options are essential steps every man should take. With early detection, the chances of successful treatment and long-term survival are significantly higher. Stay informed, prioritise regular health check-ups, and maintain a healthy lifestyle.
For expert diagnosis and world-class treatment, trust the specialised urologists and oncologists at Manipal Hospitals Global. With advanced technology, personalised care, and a patient-first approach, Manipal Hospitals offers comprehensive prostate cancer care tailored to international standards.
Every moment counts. Prostate cancer, when caught early, is highly treatable. Don’t wait for symptoms to take the lead.
Take the first step with Manipal Hospitals Global.
Learn more or book a consultation today.
Q: What are the first five indicators of prostate cancer?
A: Some early indicators are needing to urinate a lot, especially at night; having trouble starting or stopping urination; having a weak or interrupted stream of urine; having painful urination or ejaculation; and having blood in urine or semen. If you have these symptoms, you should see a doctor to rule out or confirm prostate cancer or another urinary problem.
Q: How long may a person with prostate cancer live?
A: Prostate cancer usually grows slowly. Many men who are diagnosed with this disease enjoy long, robust lives. If caught early, the five-year survival rate is almost 100%. Advanced instances are different, but treatment can greatly improve symptoms and lengthen life, letting many men survive for many years after being diagnosed.
Q: Is there a way to get rid of prostate cancer?
A: Yes, prostate cancer can be cured, especially if it is found early. Surgery and radiation therapy are two common ways to treat illnesses. Even at advanced stages, contemporary treatments can effectively control the disease, control symptoms, and significantly extend life expectancy, which improves the patient's quality of life over time.
Q: What is the best way to treat prostate cancer?
A: The stage of the cancer, the patient's overall health, and their preferences all have a role in how it is treated. You can choose active surveillance, surgery (prostatectomy), radiation, hormone therapy, or a mix of these. Cancers that are still in their early stages may not need therapy right now. An expert's assessment helps figure out the best and most tailored way to get the best results.
Q: How to find prostate cancer?
A: Regular screenings are needed to find prostate cancer. A blood test for Prostate-Specific Antigen (PSA) and a Digital Rectal Exam (DRE) are part of this. If the results are not normal, imaging and a prostate biopsy are done to make sure the diagnosis is correct. Finding the disease early greatly increases the chances of successful therapy and survival overall.
Q: What can we do to stop prostate cancer?
A: A healthy lifestyle can lower the chance of prostate cancer, but it can't be completely stopped. Eat a good diet, get regular exercise, keep your weight in check, don't smoke, and limit how much red meat you eat. Regular checkups and screenings help find problems early so that action can be taken right away.